YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
Primary liver cancer comprises a diverse group of liver tumors. The heterogeneity of these tumors is seen as one of the obstacles to finding an effective therapy. The Hippo pathway, with its downstream transcriptional co-activator Yes-associated protein (YAP) and transcriptional co-activator with PD...
Wedi'i Gadw mewn:
Prif Awduron: | Matthias Van Haele, Iván M. Moya, Ruçhan Karaman, Guy Rens, J. Snoeck, Olivier Govaere, Frederik Nevens, Chris Verslype, Baki Topal, Diethard Monbaliu, Georg Halder, Tania Roskams |
---|---|
Fformat: | Artigo |
Iaith: | Saesneg |
Cyhoeddwyd: |
2019
|
Mynediad Ar-lein: | https://doi.org/10.3390/ijms20030638 https://www.mdpi.com/1422-0067/20/3/638/pdf?version=1549024629 |
Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|
Eitemau Tebyg
-
YAP and TAZ Heterogeneity in Primary Liver Cancer: An Analysis of Its Prognostic and Diagnostic Role
gan: Van Haele, Matthias, et al.
Cyhoeddwyd: (2019) -
Peritumoral activation of the Hippo pathway effectors YAP and TAZ suppresses liver cancer in mice
gan: Iván M. Moya, et al.
Cyhoeddwyd: (2019) -
High‐throughput sequencing identifies aetiology‐dependent differences in ductular reaction in human chronic liver disease
gan: Olivier Govaere, et al.
Cyhoeddwyd: (2018) -
The PDGFRα-laminin B1-keratin 19 cascade drives tumor progression at the invasive front of human hepatocellular carcinoma
gan: Olivier Govaere, et al.
Cyhoeddwyd: (2017) -
Human Liver Regeneration: An Etiology Dependent Process
gan: Van Haele, Matthias, et al.
Cyhoeddwyd: (2019)